368 related articles for article (PubMed ID: 27690272)
1. Considerations for successful cancer immunotherapy in aged hosts.
Hurez V; Padrón ÁS; Svatek RS; Curiel TJ
Clin Exp Immunol; 2017 Jan; 187(1):53-63. PubMed ID: 27690272
[TBL] [Abstract][Full Text] [Related]
2. Considerations for successful cancer immunotherapy in aged hosts.
Hurez V; Padrón Á; Svatek RS; Curiel TJ
Exp Gerontol; 2018 Jul; 107():27-36. PubMed ID: 28987644
[TBL] [Abstract][Full Text] [Related]
3. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
4. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
Jackaman C; Nelson DJ
Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067
[TBL] [Abstract][Full Text] [Related]
5. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
6. Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors.
Stahl M; Gedrich R; Peck R; LaVallee T; Eder JP
Immunotherapy; 2016 Jun; 8(7):767-74. PubMed ID: 27349976
[TBL] [Abstract][Full Text] [Related]
7. Considerations and Approaches for Cancer Immunotherapy in the Aging Host.
Ontiveros CO; Murray CE; Crossland G; Curiel TJ
Cancer Immunol Res; 2023 Nov; 11(11):1449-1461. PubMed ID: 37769157
[TBL] [Abstract][Full Text] [Related]
8. Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.
Tuettenberg A; Steinbrink K; Schuppan D
Nanomedicine (Lond); 2016 Oct; 11(20):2735-2751. PubMed ID: 27658725
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells: Multi-talented immune suppressive cells that can be either helpful or harmful.
Cell Immunol; 2021 Jul; 365():104374. PubMed ID: 34038759
[No Abstract] [Full Text] [Related]
10. Immunosenescence and cancer.
Pawelec G
Biogerontology; 2017 Aug; 18(4):717-721. PubMed ID: 28220304
[TBL] [Abstract][Full Text] [Related]
11. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
12. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
13. Oncology meets immunology: the cancer-immunity cycle.
Chen DS; Mellman I
Immunity; 2013 Jul; 39(1):1-10. PubMed ID: 23890059
[TBL] [Abstract][Full Text] [Related]
14. MDSC; the Most Important Cell You Have Never Heard Of.
Tesi RJ
Trends Pharmacol Sci; 2019 Jan; 40(1):4-7. PubMed ID: 30527590
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of immune evasion in breast cancer.
Bates JP; Derakhshandeh R; Jones L; Webb TJ
BMC Cancer; 2018 May; 18(1):556. PubMed ID: 29751789
[TBL] [Abstract][Full Text] [Related]
16. High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.
Kalathil SG; Thanavala Y
Cancer Immunol Immunother; 2016 Jul; 65(7):813-9. PubMed ID: 26910314
[TBL] [Abstract][Full Text] [Related]
17. Innate myeloid cells in the tumor microenvironment.
Duhan V; Smyth MJ
Curr Opin Immunol; 2021 Apr; 69():18-28. PubMed ID: 33588308
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils in cancer.
Treffers LW; Hiemstra IH; Kuijpers TW; van den Berg TK; Matlung HL
Immunol Rev; 2016 Sep; 273(1):312-28. PubMed ID: 27558343
[TBL] [Abstract][Full Text] [Related]
19. Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden.
Rui K; Tian J; Tang X; Ma J; Xu P; Tian X; Wang Y; Xu H; Lu L; Wang S
Immunol Res; 2016 Aug; 64(4):931-9. PubMed ID: 26832917
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.
Hwang I; Nguyen N
Arch Pharm Res; 2015 Aug; 38(8):1415-33. PubMed ID: 25634101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]